Generics makers appeal ruling on patents for Pozen's Treximet

09/8/2011 | MedCityNews.com

Alphapharm, Dr. Reddy's Laboratories and Par Pharmaceutical appealed a court decision that upholds patents covering Pozen's migraine drug Treximet. The ruling blocks FDA approval of the firms' generic versions before patent expiration.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA